Serum glial fibrillary acidic protein (sGFAP) levels are reduced by fingolimod treatment and prognosticate disease progression independent of relapse activity in multiple sclerosis
- AM Maceski (Author)
- P Benkert (Author)
- J Oechtering (Author)
- S Schädelin (Author)
- A Zadic (Author)
- JFV Gomez (Author)
- L Melie-Garcia (Author)
- A Cagol (Author)
- R Galbusera (Author)
- S Subramaniam (Author)
- J Lorscheider (Author)
- B Fischer-Barnicol (Author)
- L Achtnichts (Author)
- O Findling (Author)
- P Lalive (Author)
- M Uginet (Author)
- S Müller (Author)
- C Pot (Author)
- A Mathias (Author)
- R Du Pasquier (Author)
- R Hoepner (Author)
- A Chan (Author)
- G Disanto (Author)
- C Zecca (Author)
- D Conen (Author)
- A Buser (Author)
- M DSouza (Author)
- Ö Yaldizli (Author)
- T Derfuss (Author)
- C Gobbi (Author)
- Khalil, M. (Author)
- D Brassat (Author)
- PMC Janiaud (Author)
- L Hemkens (Author)
- JR Oksenberg (Author)
- H Wiendl (Author)
- K Berger (Author)
- M Hermesdorf (Author)
- F Piehl (Author)
- L Kappos (Author)
- A Abdelhak (Author)
- C Granziera (Author)
- E Willemse (Author)
- D Leppert (Author)
- J Kuhle (Author)
Activity: Talk, presentation or poster › Scientific talk or presentation › On site